Access to atypical antipsychotics: a public payor's perspective.
Haveman
J K
JK
D014150:Antipsychotic Agents / Q000191:economics*; D017281:Cost of Illness; D006297:Health Services Accessibility / Q000191:economics*; D006801:Humans; D008329:Managed Care Programs / Q000191:economics / Q000458:organization & administration; D008483:Medical Assistance; D008824:Michigan; D017150:Public Sector; D012559:Schizophrenia / Q000188:drug therapy* / Q000191:economics; D014481:United States
D014150:Antipsychotic Agents